The tech giant has unveiled an update to its AI principles, which removes references to not pursuing work on weapons and surveillance.

Learn more about why Google's decision to rescind its promise to avoid using AI technology to build weapons is a concerning development.

Google’s parent company Alphabet has removed its commitment to avoiding artificial intelligence (AI) applications for weapons ...

Google has removed its pledge to avoid AI applications for weapons and surveillance from its updated AI Principles.

Google’s updated, public AI ethics policy removes its promise that it won’t use the technology to pursue applications for ...

This change, first noticed by Bloomberg, marks a shift from the company's earlier stance on responsible AI development.

"There's no real point in having regulation only in one region of the world, because AI sort of is across borders; it's going ...

The CEO of Google Mind has suggested clinical trials of the first drugs designed with the help of AI could begin this year.

Clinical trials of the first drugs designed with the help of artificial intelligence could commence this year, Google DeepMind CEO Demis Hassabis suggested Tuesday. Speaking on a panel at the World ...

Hello, everyone. And welcome to this very special session. Demis and I have done this before. But that was before his Nobel Prize. So it's the right place to start. What was it like? Well ...

“We’ll hopefully have some AI-designed drugs in clinical trials by the end of the year,” Demis Hassabis, who leads both Alphabet Inc. subsidiaries, said on a panel at the World Economic Forum in Davos ...